Explore more publications!

Press Releases

Persica Pharmaceuticals' Positive Clinical Data for PP353 Treatment of Chronic Low Back Pain Published in The Lancet's eClinicalMedicine
Cognition Therapeutics Extends Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
Chiesi Global Rare Diseases Reinforces Long-Term Commitment to the Rare Disease Community with Multiple Abstract Presentations at the 22nd Annual WORLDSymposium™
‘When senior clinicians speak with a shared voice, it matters’: RCP publishes summary of January 2026 Council meeting

‘When senior clinicians speak with a shared voice, it matters’: RCP publishes summary of January 2026 Council meeting

Angitia Biopharmaceuticals Announces $130 Million Series D Financing
Medsynaptic Named 'Best in KLAS' 2026 Winner for PACS (Global) – Asia Segment
Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant
PathMaker Neurosystems Board Director, John Donoghue, Ph.D., Awarded 2026 Queen Elizabeth Prize for Engineering
From NFL to the Clinic: Same-Day Custom Orthoses Expand Nationwide
Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program
FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia
4 Principles, Real Impact: How Hospitals Are Advancing Maternal Health
Polaryx Therapeutics Welcomes New Members of the Board of Directors
Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Shareholder Rights Law Firm Robbins LLP Urges MCTA Investors to Contact the Firm About Their Rights Against Charming Medical, Limited
Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Emerging Outlook: Biotech Summit 2026
BioPhy Acquired by Intrinsic Clinical Systems
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Chiesi Global Rare Diseases Reinforces Long-Term Commitment to the Rare Disease Community with Multiple Abstract Presentations at the 22nd Annual WORLDSymposium™

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions